Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q7Z333
UPID:
SETX_HUMAN
Alternative names:
Amyotrophic lateral sclerosis 4 protein; SEN1 homolog; Senataxin
Alternative UPACC:
Q7Z333; A2A396; B2RPB2; B5ME16; C9JQ10; O75120; Q3KQX4; Q5JUJ1; Q68DW5; Q6AZD7; Q7Z3J6; Q8WX33; Q9H9D1; Q9NVP9
Background:
Senataxin, known as Probable helicase senataxin and alternatively named Amyotrophic lateral sclerosis 4 protein and SEN1 homolog, plays a pivotal role in RNA metabolism, genomic integrity, and transcription regulation. It is essential for mRNA splicing, R-loop RNA-DNA hybrid resolution, and DNA damage response. Senataxin's involvement in circadian rhythm regulation and neurite outgrowth underscores its multifaceted biological significance.
Therapeutic significance:
Senataxin is linked to Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (SCAN2) and Amyotrophic lateral sclerosis 4 (ALS4), diseases characterized by progressive neurodegeneration. Understanding Senataxin's role could pave the way for novel therapeutic strategies targeting these debilitating conditions.